Dr. Jacqueline Lui, President of Eagle IP Group, spoke at the Breakout Session on Patent Commercialization at the 5th Annual US-China IP Conference in Shenzhen.

The conference was an annual event co-hosted by China Renmin University IP Academy, Berkeley Center for Law and Technology and Loyola Law School Los Angeles. The 5th US-China IP Conference, entitled “Intellectual Property and Economic Transformation”, brought together senior policymakers, judges, academics and international practitioners from China and the United States to discuss five important topics: (1) Recent Developments in Trade Secrets Law; (2) Privacy Protection under the Information Age; (3) Recent Developments in Entertainment Law; (4) Patent Commercialization; and (5) Brand Protection.

我们的过去活动

Recommended Insights

US vs CN: Foreign Filing License Requirements

2022年11月9日
In China, foreign filing requirements are generally very similar to the US — a foreign filing license is required if a foreign application is to be filed first for an invention made in the country. The Chinese equivalent to the US foreign filing license is called a confidentiality examination for foreign filing. According to Chinese […]
China Patent 2020 to 2021

China Provides Specific Directions to Strengthen Patent / Technology Protection from 2020 to 2021

2020年4月23日
China continues to progress towards its major goal of significantly strengthening IP protection within its borders. Last year it announced several proposed amendments to its patent laws. In January 2020 China and the US signed the Economic and Trade Agreement between the Government of China and US (published 16 January 2020 –“Trade Agreement”), which detailed […]

Why Do Examiners Fail to Recognize the Importance of my “Parameter Features”?

2025年5月28日
The Impact of Parameter Features on Inventiveness ”Parameter features” – numerical or mathematical expressions that define the quantity or physical properties of a subject – frequently appear as technical features within a claim. Often described as numerical ranges or measurements, they frequently play a critical role in addressing technical problems. However, in practice, Examiners and […]

How to Protect a Crystal Form (Polymorph) Patent in China

2025年6月4日
Crystalline forms are critical to pharmaceutical patents, offering extended protection for improved stability, bioavailability, or manufacturability. However, securing such patents in China has grown increasingly difficult due to the China National Intellectual Property Administration (CNIPA)’s strict patentability criteria. Unlike the U.S. or Europe, where structural novelty or problem-solving utility may suffice, China demands quantifiable evidence of […]
Top crossarrow-right